EBRD Extends $23 Million Loan to Meros Pharm to Drive Expansion in Uzbekistan’s Pharmaceutical Industry

EBRD Extends $23 Million Loan to Meros Pharm to Drive Expansion in Uzbekistan’s Pharmaceutical Industry

(IN BRIEF) The European Bank for Reconstruction and Development (EBRD) has granted a loan of $23 million to Meros Pharm, a leading pharmaceutical distributor in Uzbekistan. The loan will support Meros Pharm’s expansion plans by providing the necessary working capital to establish new warehouses across the country. This expansion will improve operational efficiency, profitability, and enable the distribution of affordable medications to underserved regions. Additionally, the EBRD will assist Meros Pharm in creating job opportunities and addressing skills gaps through the establishment of an in-house training academy focused on logistics and warehousing. The EBRD’s investment demonstrates its commitment to supporting economic growth in Uzbekistan.

(PRESS RELEASE) LONDON, 18-May-2023 — /EuropaWire/ — The European Bank for Reconstruction and Development (EBRD), a multilateral developmental investment bank, announces that it is providing significant support to Meros Pharm, one of Uzbekistan‘s prominent pharmaceutical distributors. Through a loan of up to $23 million, the EBRD aims to facilitate the company’s geographical expansion by addressing its working capital requirements.

Meros Pharm has established itself as one of Uzbekistan’s largest and most successful private pharmaceutical distributors, known for its market presence and reputation. The loan will contribute to the company’s growth strategy by funding the necessary working capital for expanding its network of warehouses throughout the country. This expansion will enhance operational efficiency, profitability, and enable Meros Pharm to provide a wider range of high-quality and affordable medications to underserved areas such as Andijan, Nukus, and Bukhara.

Moreover, the EBRD will collaborate with Meros Pharm to address skills gaps and create employment opportunities in regions with limited job prospects. With targeted technical support from the EBRD, Meros Pharm will establish an in-house training academy dedicated to logistics and warehousing. This initiative is expected to benefit approximately 150 employees and new recruits annually, enhancing their employability prospects.

Meros Pharm is a part of the Meros Group, a leading vertically integrated pharmaceutical group involved in the entire value chain from production to wholesale distribution and retail.

The EBRD has emerged as a significant institutional investor in Uzbekistan, having already invested over €4 billion in 135 projects across the country, demonstrating its commitment to fostering economic development and growth.

Media contact:

Tel: +44 207 338 7805
Email: press@ebrd.com

SOURCE: EBRD